Literature DB >> 4009135

D-galactosamine-induced liver injury: a rat model to study the heterogeneity of the oligosaccharide chains of alpha 1-acid glycoprotein.

D Monnet, D Durand, D Biou, J Féger, G Durand.   

Abstract

The effect of D-galactosamine on the structure of the glycan moiety of alpha 1-acid glycoprotein was studied throughout a nine days experiment. It was shown that: D-galactosamine led to an alteration of the Concanavalin A crossed immunoelectrophoresis pattern and to a decreased sialic acid content of alpha 1-acid glycoprotein. The undersialylation of alpha 1-acid glycoprotein was not linked to a change in the relative ratio of various Concanavalin A forms. At the end of the experiment (9 days after galactosamine injection), the Concanavalin A non-reactive forms of alpha 1-acid glycoprotein remained elevated whereas alanine transaminase activity, total protein and alpha-acid glycoprotein had returned to a control level. D-galactosamine-treated rats seem to be a suitable model for the study of the very fast cyclic modulations of the synthesis of the glycan moiety of glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009135     DOI: 10.1515/cclm.1985.23.4.249

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  3 in total

1.  Variation of alpha 1-antitrypsin glycoprotein microheterogeneity in hepatic postresuscitation disease.

Authors:  K Heyne; F K Tegtmeyer; S Weidinger
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

2.  Recombinant human interleukin 1 beta and tumor necrosis factor affect glycosylation of serum alpha 1-acid glycoprotein in rats.

Authors:  C Poüs; L Chauvelot-Moachon; M Lecoustillier; G Durand
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

3.  A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus.

Authors:  Kenta Inomata; Kazuki Tajima; Hiroshi Yagi; Hisanobu Higashi; Hirofumi Shimoda; Kentaro Matsubara; Taizo Hibi; Yuta Abe; Hanako Tsujikawa; Minoru Kitago; Masahiro Shinoda; Hideaki Obara; Osamu Itano; Alejandro Soto-Gutierrez; Yuko Kitagawa
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.